Tumor necrosis factor-α mediates the early pathology in Salmonella infection of the gastrointestinal tract

Microbial Pathogenesis

Volumn 14, Issue 3, 1993, Pages 217-227

  Arnold, Judy W ^a   Niesel, David W ^a   Annable, Charles R ^b   Hess, Cynthia B ^a   Asuncion, Maria ^a   Cho, Yang Ja ^c   Peterson, Johnny W ^a   Klimpel, Gary R ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b DRISCOLL CHILDREN S HOSPITAL   (United States)

^c Hanyang University   (South Korea)

Author keywords

Intestine; Pathology; Salmonella typhimurium; TNF

Indexed keywords

RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL VIRULENCE; CONTROLLED STUDY; GASTROINTESTINAL TRACT; HISTOLOGY; MOUSE; NONHUMAN; PATHOLOGY; SALMONELLA TYPHIMURIUM; SALMONELLOSIS;

ANIMAL; ANTIBODIES; BASE SEQUENCE; BLOTTING, NORTHERN; CHOLERA TOXIN; ENTERITIS; FEMALE; ILEITIS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED DBA; MOLECULAR SEQUENCE DATA; SALMONELLA INFECTIONS, ANIMAL; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR NECROSIS FACTOR;

EID: 0027276490     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1006/mpat.1993.1021     Document Type: Article

References (25)

1. f Starkey WG, Stephen J, Haddon SJ, Osborne MP, Candy DLA. The nature and role of mucosal damage in relation to Salmonella typhimurium induced fluid secretion in the rabbit ileum. J Med Microbiol 1986; 22: 39-49.
2. Finkeistein RA. Structure of the cholera enterotoxin (choleragen) and the immunologically related ADP-ribosylation heat labile enterotoxins. In: Hardegree MC, Tu AT, eds. Handbook of natural toxins, vol. 4, bacterial toxins. New York: Dekker, 1988; 1-38.
3. Gots RE, Formal SB, Giannella RA. Indomethacin inhibition of Salmonella typhimurium, Shigella flexneri and cholera-mediated rabbit ileal secretion, J Invest Dis 1974; 130: 280-4.
4. Nakano Y, Onozuka K, Teroda Y, Shinomuja H, Nakano M. Protective effects of recombinant tumor necrosis factor-a in murine salmonellosis. J Immunol 1990; 144:1935-41.
5. Sandefur PD, Peterson JW. Neutralization of Salmonella toxin-induced elongation of Chinese hamster ovary cells by cholera antitoxin. Infect Immun 1977; 15: 988-92.
6. Finkelstein RA, Marchlewicz BA, McDonald RA, Boesman-Finkelstein M. Isolation and characterization of a cholera-treated enterotoxin from Salmonella typhimurium. FEMS Lett 1983; 17: 239-41.
7. Wallis TS, Starkey WG, Stephen J, Haddon SJ, Osborne MP, Candy DCA. Enterotoxin production by Salmonella typhimurium strains of different virulence. J Med Microbiol 1986; 21:19-23.
8. Koo FCW, Peterson JW, Houston CW, Molina NC. Pathogenesis of experimental salmonellosis: Inhibition of protein synthesis by cytotoxin. Infect Immun 1984; 43; 93-100.
9. Giannella RA, Formal SB, Dammin GJ, Collins H. Pathogenesis of salmonellosis. Studies on fluid secretion, mucosal invasion, and morphological reaction in the rabbit ileum. J Clin Invest 1973; 52: 441-53.
10. Wallis TS, Vaughan ATM, Clarke GJ, Qet G-M, Worton KJ, Candy DCA, Osborne MP, Stephen J. The role of leucocytes in the induction of fluid secretion by Salmonella typhimurium. J Med Microbial 1990; 31:27-35.
11. Grau G, Fajardo LF, Piguet PF, AI let B, Lambert PH, Vassalli P. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science 1987; 237:1210-12.
12. Kindler V, Sappino AP, Grau G, Piguet PF, Vassalli P. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 1989; 56: 731-40.
13. Nakane A, Minagawa T, Kato K. Endogenous tumor necrosis factor is essential to host resistance against Listeria monocytogenes infection. Infect Immun 1988; 56: 2563-9.
14. Beutler BA, Greenwald D, Holmes JD, Chang M, Pan YCE, Matheson J, Ulerich R, Cerami A. Identity of tumor necrosis factor and the macrophage secreted factor cachectin. Nature 1989; 316: 552-4.
15. Tracey KJ, Fong Y, Hesse DG, Manogue KR, Lee AT, Kuo GL, Lowry SF, Cerami A. Anti-cachectin TNF monoclonal antibodies prevent septic shock during lethal bacteracemta. Nature 1987; 330: 662-4.
16. Beutler BA, Milsark IW, Cerami A. Cachectin/tumor necrosis factor: production, distribution and metabolic fate in vivo. J Immunol 1985; 135: 3972-7.
17. Remick DG, Kunkel RG, Larrich JW, Kunkel SL. Acute in vivo effects of human recombinant tumor necrosis factor. Lab Invest 1987; 56: 583-90.
18. Peterson JW, Ochoa LG. Role of prostaglandins and cAMP in the secretory effects of cholera toxin. Science 1989; 245: 857-9.
19. Moss J, Vaughan M. Cholera toxin and E. coli enterotoxins and their mechanisms of action. In: Hardegree MC, Tu AT, eds. Handbook of natural toxins, vol. 4, bacterial toxins. New York: Dekker, 1988; 39-87.
20. Klimpel GR, Shaban R, Niesei DW. Bacteria-infected fibroblasts have enhanced susceptibility to the cytotoxic action of tumor necrosis factor. J Immunol 1990; 145: 711-17.
21. Hess CB, Ntesel DW, Klimpel GR. The induction of interferon production by invasive bacteria: A comparison of Shigella and Salmonella sp. Microb Pathogen 1989; 7: 111 -20.
22. Gianella RA, Formal SB, Dammin GJ, Collins H. Pathogenesis of Salmonellosis studies on fluid secretion, mucosal invasion and morphologic reaction in the rabbit ¡lern. J Clin Invest 1973; 52: 441-53.
23. Weiser MM. Intestinal epithelial cell surface membrane glycoprotein synthesis. J Biol Chem 1973; 248: 2536-41.
24. Austyn JM, Gordon S. F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol 1981; 11: 805-15.
25. Brahic M, Haase AT. Double-label techniques of in situ hybridization and immunocytochemistry. Curr Top Microb Immunol 1989; 143: 9-20.